Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
Authors
Keywords
-
Journal
BIOSCIENCE REPORTS
Volume 38, Issue 6, Pages BSR20181304
Publisher
Portland Press Ltd.
Online
2018-11-26
DOI
10.1042/bsr20181304
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: Effects of statins and antidiabetic drugs
- (2017) Niki Katsiki et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Liraglutide and Renal Outcomes in Type 2 Diabetes
- (2017) Johannes F.E. Mann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: A systematic review and meta-analysis
- (2017) Sophie Pettit et al. PLoS One
- Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β
- (2017) Kevin M. Hart et al. Science Translational Medicine
- High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men
- (2017) Jieun Lee et al. PLoS One
- Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors
- (2016) M. Nauck DIABETES OBESITY & METABOLISM
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Effects of Low-Fat Diets Differing in Protein and Carbohydrate Content on Cardiometabolic Risk Factors during Weight Loss and Weight Maintenance in Obese Adults with Type 2 Diabetes
- (2016) Nerylee Watson et al. Nutrients
- Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms
- (2015) Chiara Saponaro et al. Current Diabetes Reports
- Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study
- (2015) Ali A Rizvi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease
- (2015) X. Lin et al. GENETICS AND MOLECULAR RESEARCH
- Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease
- (2015) Cristina Alina Silaghi et al. Medical Ultrasonography
- Type 2 diabetes mellitus
- (2015) Ralph A. DeFronzo et al. Nature Reviews Disease Primers
- Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials胰高血糖素样肽-1类似物对非糖尿病肥胖/超重成人的减重作用:一篇对随机对照试验进行的系统评价及meta分析
- (2014) Fang Zhang et al. Journal of Diabetes
- Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats
- (2013) Melissa A. Linden et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease
- (2013) H. Kahal et al. CLINICAL ENDOCRINOLOGY
- Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetes
- (2013) A.J. Scheen et al. DIABETES & METABOLISM
- Effects of Liraglutide, a Human Glucagon-like Peptide-1 Analogue, on Body Weight, Body Fat Area and Body Fat-related Markers in Patients with Type 2 Diabetes Mellitus
- (2013) Daisuke Suzuki et al. INTERNAL MEDICINE
- Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
- (2013) Richard S. Legro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Potential of incretin-based therapies for non-alcoholic fatty liver disease
- (2013) Susan L. Samson et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis
- (2013) Louise E Robinson et al. BMJ Open
- Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study
- (2012) M. Nauck et al. DIABETES OBESITY & METABOLISM
- Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
- (2012) Daniel J. Cuthbertson et al. PLoS One
- Metformin regulates hepatic lipid metabolism through activating AMP-activated protein kinase and inducing ATGL in laying hens
- (2011) Wei-Lu Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients
- (2011) Esther Zimmermann et al. JOURNAL OF HEPATOLOGY
- Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis
- (2011) Gianluca Svegliati-Baroni et al. LIVER INTERNATIONAL
- Effects of Combined Exenatide and Pioglitazone Therapy on Hepatic Fat Content in Type 2 Diabetes
- (2011) Padma Sathyanarayana et al. Obesity
- A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus
- (2010) Eduard Montanya et al. CLINICAL THERAPEUTICS
- Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study
- (2010) G A Garinis et al. INTERNATIONAL JOURNAL OF OBESITY
- Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes
- (2010) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Low Serum Adiponectin Levels Are Predictive of Advanced Hepatic Fibrosis in Patients With NAFLD
- (2009) Savvoula Savvidou et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome
- (2009) E. Maury et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis
- (2008) R. LOOMBA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis
- (2008) A.E. Nieuwenhuis-Ruifrok et al. HUMAN REPRODUCTION UPDATE
- Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
- (2008) Alan Garber et al. LANCET
- NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men
- (2008) Giovanni Targher et al. Obesity
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More